MoonLake Immunotherapeut... Stock Quote MLTX - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

53.71

Bid

51.48

Ask

54.75

Volume

294,511

53.03 Day's Range 54.91

35.11 52 Week Range 64.98

Market Cap

3.431B

Previous Close

53.11

Open

54.10

Last Trade

53.71

Last Trade Time

Financial Volume

$ 15,899,713

VWAP

53.9868

Average Volume (3m)

326,554

Shares Outstanding

63,883,904

Dividend Yield

PE Ratio

-77.84

Earnings Per Share (EPS)

-0.69

Revenue

Net Profit

-44.08M

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Sector

Blank Checks

Industry

Pharmaceutical Preparations

Website

moonlaketx.com

Headquarters

Grand Cayman, Cym

Founded

2020

MoonLake Immunotherapeutics is listed in the Blank Checks sector of the NASDAQ with ticker MLTX. The last closing price for MoonLake Immunotherapeut... was $53.11. Over the last year, MoonLake Immunotherapeut... shares have traded in a share price range of $ 35.11 to $ 64.98.

MoonLake Immunotherapeut... currently has 63,883,904 shares outstanding. The market capitalization of MoonLake Immunotherapeut... is $3.39 billion. MoonLake Immunotherapeut... has a price to earnings ratio (PE ratio) of -77.84.

Form 8-K - Current report

MoonLake Immunotherapeutics to host a Capital Markets Update on Wednesday, September 11

MoonLake Immunotherapeutics to host a Capital Markets Updateon Wednesday, September 11 ZUG, Switzerland, September 9, 2024 – MoonLake Immunotherapeutics AG (“MoonLake”; Nasdaq: MLTX), a...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11

MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11 Initiated Phase 3 VELA program of the Nanobody® sonelokimab in...

Form 8-K - Current report

MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis

MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis Builds upon the...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	6.72	14.3009150883	46.99	55.05	46.8	459074	51.5612461	CS
4	4.28	8.65870928586	49.43	55.05	44.71	245084	49.17442739	CS
12	13.36	33.1102850062	40.35	55.05	39.36	326554	45.80407321	CS
26	5.16	10.6282183316	48.55	55.05	37.55	341926	44.71868396	CS
52	-3.82	-6.64001390579	57.53	64.98	35.11	470296	48.71589181	CS
156	41.34	334.1956346	12.37	64.98	4.25	351397	42.24511754	CS
260	41.34	334.1956346	12.37	64.98	4.25	351397	42.24511754	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GSIWGarden Stage Ltd	$ 8.17 (259.91%)	70.64M
ZEOZeo Energy Corporation	$ 2.5995 (128.03%)	59.98M
TBIOTelesis Bio Inc	$ 2.9201 (114.71%)	53.74M
NCINeo Concept International Group Holdings Ltd	$ 0.84 (71.43%)	12.68M
VEROVenus Concept Inc	$ 0.8475 (68.66%)	20.56M
HAOHaoxi Health Technology Ltd	$ 0.83 (-72.33%)	7.93M
PGNYProgyny Inc	$ 16.465 (-32.63%)	17.44M
NUZENuZee Inc	$ 0.6998 (-32.06%)	14.04M
RGFReal Good Food Company Inc	$ 0.308 (-28.37%)	360.79k
ALGSAligos Therapeutics Inc	$ 10.18 (-28.11%)	839.92k
NVDANVIDIA Corporation	$ 117.87 (3.97%)	293.54M
SQQQProShares UltraPro Short QQQ	$ 7.76 (-7.62%)	222.56M
HOLOMicroCloud Hologram Inc	$ 0.2328 (15.08%)	120.19M
MAXNMaxeon Solar Technologies Ltd	$ 0.1034 (13.75%)	105.03M
TSLATesla Inc	$ 243.92 (7.36%)	102.7M